The Swedish Study of Irrigation Fluid Temperature in the Evacuation of Chronic Subdural Hematoma

NCT02757235 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 588

Last updated 2022-02-28

No results posted yet for this study

Summary

The study will be a multicenter randomised controlled trial of the use of irrigation fluid of body temperature versus irrigation fluid of room temperature during burr hole evacuation of chronic subdural hematoma.

Conditions

  • Chronic Subdural Hematoma

Interventions

PROCEDURE

Irrigation fluid of body temperature

Irrigation fluid of body temperature will be used during burr hole evacuation of chronic subdural hematoma

PROCEDURE

Irrigation fluid of room temperature

Irrigation fluid of room temperature will be used during burr hole evacuation of chronic subdural hematoma.

Sponsors & Collaborators

  • Karolinska University Hospital

    collaborator OTHER
  • Uppsala University Hospital

    collaborator OTHER
  • Sahlgrenska University Hospital

    lead OTHER

Principal Investigators

  • Asgeir Jakola, MD, PhD · Sahlgrenska University Hospital, Department of neurosurgery

  • Niklas Marklund, MD, Phd · Akademiska University Hospital, Department of neurosurgery

  • Jimmy Sundblom, MD, Phd · Akademiska University Hospital, Department of neurosurgery

  • Jiri Bartek, MD · Karolinska University Hospital, Department of neurosurgery

  • Andreas Bartley, MD · Sahlgrenska University Hospital, Department of neurosurgery

  • Magnus Tisell, MD, PhD · Sahlgrenska Universtiy Hospital, Department of neurosurgery

  • Petter Förander, MD, PhD · Karolinska University Hospital, Department of neurosurgery

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2020-10-31
Completion
2020-10-20

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02757235 on ClinicalTrials.gov